Clinigen ups dividend as it reports strong growth
Shares in global pharmaceutical and services company Clinigen (CLIN:AIM) traded 1.5% higher to 657p on Thursday as it raised its dividend after reporting strong second half cash flows and continued organic growth with revenues up 4%...
17 September 2020